The ongoing trade war between the US and China will have huge ramifications on the biopharmaceutical industry for both countries. However, it appears that China is in a much better position from a negotiation standpoint, according to leading data and analytics company . On 3 April 2018, the US Trade Representative’s (USTR) office announced its […]